Mesuximide (or methsuximide, methosuximide) is a succinimide anticonvulsant
medication. It is sold as a racemate by Pfizer under the tradenames Petinutin ...
Each Celontin capsule contains 300 mg methsuximide, USP. Also contains
starch, NF. The capsule contains colloidal silicon dioxide, NF; D&C yellow No.
Easy to read patient leaflet for methsuximide. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Methsuximide suppresses the paroxysmal three cycle per second spike and
wave activity associated with lapses of consciousness which is common in
Sep 1, 2015 ... Methsuximide is used to control absence (petit mal) seizures in the treatment of
epilepsy. It is used after other medicines have been tried, but ...
May 16, 2016 ... Methsuximide is an anti-epileptic medication, also called an anticonvulsant.
Drug information on Celontin (methsuximide), includes drug pictures, side effects,
drug interactions, directions for use, symptoms of overdose, and what to avoid.
Oct 30, 2007 ... Description, Mesuximide (or methsuximide) is an anticonvulsant medication. It is
sold by Pfizer under the name Petinutin. [Wikipedia]. Structure.
(methsuximide). Capsules. Read this Medication Guide before you start taking
CELONTIN and each time you get a refill. There may be new information.
Consumer information about the medication METHSUXIMIDE - ORAL (Celontin),
includes side effects, drug interactions, recommended dosages, and storage ...